Portfolio / Okapi Biosciences

Logo-Okapi.jpg

Okapi Sciences was a Belgium based biopharmaceutical company focused on the licensing, development and commercialization of innovative antiviral drugs for livestock and pets. Okapi was started by and spun out from the University of Leuven (KU Leuven). Okapi was acquired by Aratana Therapeutics Inc. in 2014.

Visit the website

Company

Okapi Biosciences

Fund

I

Status

Realized

Team member

Harrold van Barlingen

Technology

Icons-Creteria_Medical-technologymedical-devices.png

Therapeutics